General form of registration statement for all companies including face-amount certificate companies

Schedule of Assets Acquired and Liabilities Assumed (Details)

v3.21.4
Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Jul. 15, 2019
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Jul. 31, 2019
Dec. 31, 2018
Business Acquisition [Line Items]            
Total acquired identifiable intangible assets $ 7,300          
Goodwill   $ 8,433 $ 8,433 $ 8,433  
BioPharma Acquisition [Member]            
Business Acquisition [Line Items]            
Cash 13,829          
Subordinated note payable 6,822          
Total consideration 20,651          
Accounts receivable 3,731          
Accrued revenue 289          
Lab supplies 877          
Prepaid expenses 266          
Property and equipment 6,412          
Operating lease assets 2,187          
Total acquired identifiable intangible assets 7,300       $ 7,300  
Goodwill 8,273     $ 100 $ 8,300  
Total assets acquired 29,335          
Accounts payable (4,535)          
Accrued liabilities (435)          
Deferred revenue (1,076)          
Operating lease liabilities (2,187)          
Finance lease liabilities (451)          
Total liabilities assumed (8,684)          
Net assets acquired 20,651          
BioPharma Acquisition [Member] | Trademarks and Trade Names [Member]            
Business Acquisition [Line Items]            
Total acquired identifiable intangible assets 1,600          
BioPharma Acquisition [Member] | Customer Relationships [Member]            
Business Acquisition [Line Items]            
Total acquired identifiable intangible assets $ 5,700